pentobarbital has been researched along with Hearing Loss, Sensorineural in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, AM | 1 |
| Cahill, LD | 1 |
| Ret, J | 1 |
| Schmithorst, V | 1 |
| Choo, D | 1 |
| Holland, S | 1 |
1 other study available for pentobarbital and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Functional magnetic resonance imaging of hearing-impaired children under sedation before cochlear implantation.
Topics: Acoustic Stimulation; Audiometry, Pure-Tone; Auditory Cortex; Auditory Threshold; Child, Preschool; | 2007 |